1-9 of 9
Shirley Bartido
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safe mobilization of CD34 + cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

Brief Report
Farid Boulad, Xiuyan Wang, Jinrong Qu, Clare Taylor, Leda Ferro, Garyfalia Karponi, Shirley Bartido, Patricia Giardina, Glenn Heller, Susan E. Prockop, Aurelio Maggio, Michel Sadelain, Isabelle Rivière
Journal: Blood
Blood (2014) 123 (10): 1483–1486.
https://doi.org/10.1182/blood-2013-06-507178
Published: 2014
Includes: Supplemental data
Journal Articles

Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy

Marco L Davila, MD, PhD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Shirley Bartido, PhD, Jolanta Stefanski, Qing He, Oriana Borquez-Ojeda, Clare Taylor, MSc, Teresa Wasielewska, Jinrong Qu, Diana CG Bouhassira, BS, Yvette J Bernal, MS, Sarah Yoo, Terence Purdon, Elizabeth Halton, RN, MS, ANP, Hilda Quintanilla, RN, MS, ANP, Jae H Park, MD, Kevin J. Curran, MD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 69.
https://doi.org/10.1182/blood.V122.21.69.69
Published: 2013
Journal Articles

Phase I Trial Of Autologous CD19-Targeted CAR-Modified T Cells As Consolidation After Purine Analog-Based First-Line Therapy In Patients With Previously Untreated CLL

Jae H Park, MD, Isabelle Rivière, PhD, Xiuyan Wang, PhD, Jolanta Stefanski, Qing He, Oriana Borquez-Ojeda, Teresa Wasielewska, Clare Taylor, MSc, Jinrong Qu, Shirley Bartido, PhD, Yvette J Bernal, MS, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 874.
https://doi.org/10.1182/blood.V122.21.874.874
Published: 2013
Journal Articles

First US Phase I Clinical Trial Of Globin Gene Transfer For The Treatment Of Beta-Thalassemia Major

Farid Boulad, MD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Shirley Bartido, PhD, Susan E. Prockop, MD, Rita Barone, M.D., Paolo Moi, MD, Aurelio Maggio, M.D., Michel Sadelain, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 716.
https://doi.org/10.1182/blood.V122.21.716.716
Published: 2013
Journal Articles

Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL

Jae H. Park, MD, Isabelle Rivière, PhD, Xiuyan Wang, PhD, Jolanta Stefanski, Qing He, Clare Taylor, MSc, Malgorzata Olszewska, Teresa Wasielewska, Shirley Bartido, PhD, Marco L Davila, MD, PhD, Yvette Bernal, Nicole Lamanna, MD, Ariela Noy, MD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1797.
https://doi.org/10.1182/blood.V120.21.1797.1797
Published: 2012
Journal Articles

Molecular Remission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 19–28z CAR-Targeted T Cells

Marco L Davila, MD, PhD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Jae H. Park, MD, Jolanta Stefanski, Clare Taylor, MSc, Qing He, Malgorzata Olszewska, Teresa Wasielewska, Oriana Borquez-Ojeda, Jinrong Qu, Shirley Bartido, PhD, Joseph G. Jurcic, MD, Dan Douer, MD, Mark G. Frattini, MD, PhD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3566.
https://doi.org/10.1182/blood.V120.21.3566.3566
Published: 2012
Journal Articles

CD19 Targeted Allogeneic EBV-Specific T Cells for the Treatment of Relapsed ALL in Pediatric Patients Post HSCT

Kevin J. Curran, MD, Nancy A. Kernan, MD, Xiuyan Wang, PhD, Clare Taylor, MSc, Ekaterina Doubrovina, MD, PhD, Shirley Bartido, PhD, Michel Sadelain, MD, PhD, Richard J. O'Reilly, MD, Renier J Brentjens, MD, PhD, Isabelle Rivière, PhD
Journal: Blood
Blood (2012) 120 (21): 353.
https://doi.org/10.1182/blood.V120.21.353.353
Published: 2012
Journal Articles

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Clinical Trials & Observations
Renier J. Brentjens, Isabelle Rivière, Jae H. Park, Marco L. Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Borquez-Ojeda, Malgorzata Olszewska, Yvette Bernal, Hollie Pegram, Mark Przybylowski, Daniel Hollyman, Yelena Usachenko, Domenick Pirraglia, James Hosey, Elmer Santos, Elizabeth Halton, Peter Maslak, David Scheinberg, Joseph Jurcic, Mark Heaney, Glenn Heller, Mark Frattini, Michel Sadelain
Journal: Blood
Blood (2011) 118 (18): 4817–4828.
https://doi.org/10.1182/blood-2011-04-348540
Published: 2011
Includes: Supplemental data
Journal Articles

B Cell Aplasia In a Patient with Relapsed B Cell Acute Lymphoblastic Leukemia Following Re-Induction and Consolidation with Autologous T Cells Genetically Targeted to the CD19 Antigen

Marco L Davila, MD, PhD, Clare Taylor, MSc, Xiuyan Wang, PhD, Jolanta Stefanski, Malgorzata Olszewska, Shirley Bartido, PhD, Mark Frattini, MD, Michel Sadelain, MD, PhD, Isabelle Rivière, PhD, Renier J. Brentjens, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3268.
https://doi.org/10.1182/blood.V116.21.3268.3268
Published: 2010